The involvement of aldose reductase in alterations to neurotrophin receptors and neuronal cytoskeletal protein mRNA levels in the dorsal root ganglion of streptozotocin-induced diabetic rats

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 1, 2010, Pages 67-71

  Shimoshige, Yukinori ^a   Enomoto, Ryugo ^a   Aoki, Toshiaki ^a   Matsuoka, Nobuya ^a   Kaneko, Shuji ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Aldose reductase inhibitor; Diabetic neuropathy; Dorsal root ganglia; Neuronal cytoskeletal protein; Neurotrophin

Indexed keywords

ALDEHYDE REDUCTASE; ALPHA TUBULIN; BETA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYTOSKELETON PROTEIN; GLUCOSE; MESSENGER RNA; NEUROFILAMENT H; NEUROFILAMENT L; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; NEURONAL CYTOSKELETON PROTEIN; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; POLYOL; PROTEIN TYROSINE KINASE A; UNCLASSIFIED DRUG; ZENARESTAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEUROPATHY; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; MALE; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPINAL GANGLION; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ALDEHYDE REDUCTASE; ANIMALS; CYTOSKELETAL PROTEINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENZYME INHIBITORS; GANGLIA, SPINAL; MALE; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; POLYMERS; QUINAZOLINES; RATS; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUBULIN;

EID: 75149130512     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.67     Document Type: Article

References (45)

1. Vinik A. I., Liuzzi F. J., Holland M. T., Stansberry K. B., Le Beau J. M., Colen L. B., Diabetes Care, 15, 1926-1975 (1992).
2. Jakobsen J., Lundbæk K., BMJ, 2, 278-279 (1976).
3. Gbrosova I. G., Huysen C. V., Fathallah L., Cao X., Green D. A., Stevens M. J., FASAB J., 16, 123-125 (2002).
4. Schmeichel A. M., Schmelzer J. D., Low P. A., Diabetes, 52, 165-171 (2003).
5. Furukawa S., Furukawa Y., Cerebrovasc. Brain Metab. Rev., 2. 328-344 (1990).
6. Apfel S. C., Eur. Neurol., 41 (Suppl. 1), 27-34 (1999).
7. Sima A. A. F., Cell. Mol. Life Sci., 60, 2445-2464 (2003).
8. Rodríguez-Peña A., Botana M., González M., Requejo F., Neurosci. Lett., 200, 37-40 (1995).
9. Fernyhough P., Diemel L. T., Brewster W. J., Tomlinson D. R., J. Neurochem., 64, 1231-1237 (1995).
10. Tomlinson D. R., Fernyhough P., Diemel L. T., Diabetes, 46 (Suppl. 2), S43-S49 (1997).
11. Fernyhough P., Diemel L. T., Tomlinson D. R., Diabetologia, 41, 300-306 (1998).
12. Apfel S. C., Kessler J. A., Adornato B. T., Litchy W. J., Sanders C., Rask C. A., Neurology, 51, 695-702 (1998).
13. Mizisin A. P., Calcutt N. A., Tomlinson D. R., Gallagher A., Fernyhough P., J. Peripher. Nerv. Syst., 4, 211-221 (1999).
14. Huang T. J., Sayers N. M., Fernyhough P., Verkhratsky A., Diabetologia, 45, 560-570 (2002).
15. Huang T. J., Sayers N. M., Verkhratsky A., Fernyhough P., Exp. Neurol., 194, 279-283 (2005).
16. Yagihashi S., Diabetes Metab. Rev., 11, 193-225 (1995).
17. Yagihashi S., Kamijo M., Watanabe K., Am. J. Pathol., 136, 1365-1373 (1990).
18. Gasser H. S., Grundfest H., Am. J. Physiol., 127, 393-414 (1939).
19. Medori R. M., Autilio-Gambetti L., Monaco S., Gambetti P., Proc. Natl. Acad. Sci. U.S.A., 82, 7716-7720 (1985).
20. Hoffman P. N., Cleveland D. W., Griffin J. W., Landes P. W., Cowan N. J., Price D. L., Proc. Natl. Acad. Sci. U.S.A., 84, 3472-3476 (1987).
21. Gold B. G., Mobley W. C., Matheson S. F., J. Neurosci., 11, 943-955 (1991).
22. McLean W. G., Pekiner C., Cullum N. A., Casson L. F., Mol. Neurobiol., 6, 225-237 (1992).
23. Marszalek J. R., Williamson T. L., Lee M. K., Xu Z., Hoffman P. N., Becher M. W., Crawford T. O., Cleveland D. W., J. Cell Biol., 135, 711-724 (1996).
24. McLean W. G., Neurochem. Res., 22, 951-956 (1997).
25. Fernyhough P., Gallagher A., Averill S. A., Priestley J. V., Hounsom L., Patel J., Tomlinson D. R., Diabetes, 48, 881-889 (1999).
26. Ziegler D., Ann. N.Y. Acad. Sci., 1084, 250-266 (2006).
27. Constantino L., Rastelli G., Vianello P., Cignarella G., Barlocco D., Med. Res. Rev., 19, 3-23 (1999).
28. Greene D. A., Arezzo J. C., Brown M. B., The Zenarestat Study Group, Neurology, 53, 580-591 (1999).
29. Mizuno K., Kato N., Makino M., Suzuki T., Shindo M., J. Diab. Comp., 13, 141-150 (1999).
30. Shimoshige Y., Ikuma K., Yamamoto T., Takakura S., Kawamura I., Seki J., Mutoh S., Goto T., Metabolism, 49, 1395-1399 (2000).
31. Yamamoto T., Takaura S., Kawamura I., Seki J., Goto T., Life Sci., 68, 1439-1448 (2001).
32. Bril V., Buchanan R. A., The Ranirestat Study Group, Diabetes Care, 29, 68-72 (2006).
33. Zochodne D. W., Murray M. M., van der Sloot P., Riopelle R. J., Brain Res., 698, 130-136 (1995).
34. Takakura S., Minoura H., Shimoshige Y., Minoura K., Kawamura I., Fujiwara T., Saitoh T., Shimojo F., Seki J., Goto T., Drug Dev. Res., 54, 27-34 (2001).
35. Ihara C., Shimatsu H., Mizuta H., Murabe Y., Nakamura Y., Nakao K., Neuropeptides, 30, 309-312 (1996).
36. Kato N., Mizuno K., Makino M., Suzuki T., Yagihashi S., Diabetes Res. Clin. Pract., 50, 77-85 (2000).
37. Mohiuddin L., Fernyhough P., Tomlinson D. R., Diabetes, 44, 25-30 (1995).
38. Scott J. N., Clark A. W., Zochodone D. W., Brain, 122, 2109-2117 (1999).
39. Liuzzi F. J., Bufton S. M., Vinik A. I., Exp. Neurol., 154, 381-388 (1998).
40. Miller F. D., Tetzlaff W., Bisby M. A., Fawcett J. W., Milner R. J., J. Neurosci., 9, 1452-1463 (1989).
41. Wong J., Oblinger M. M., J. Neurosci. Res., 27, 332-341 (1990).
42. Fornaro M., Lee J. M., Raimondo S., Nicolino S., Geuna S., Giacobini-Robecchi M., Neuroscience, 153, 1153-1163 (2008).
43. Kuo L. -T., Groves M. J., Scaravilli F., Sugden D., An S. F., Neuroscience, 147, 491-507 (2007).
44. Tomlinson D. R., Mayer J. H., Exp. Neurol., 89, 420-427 (1985).
45. Zochodne D. W., Verge V. M. K., Cheng C., Sun H., Johnston J., Brain, 124, 2319-2334 (2001).